Intelligent Bio Solutions Inc. (INBS) Gross Margin (2022 - 2025)
Intelligent Bio Solutions (INBS) posted quarterly Gross Margin of 46.84% for Q1 2025, up 2517.0% year-over-year from 1.79% in Q1 2024, and up 27.52% quarter-over-quarter from 36.73% in Q4 2024.
Intelligent Bio Solutions Inc. (INBS) Gross Margin (2022 - 2025) Analysis & Trends
Intelligent Bio Solutions' Gross Margin history runs 4 years deep, the most recent figure standing at 46.84% for Q1 2025.
- In Q1 2025, Gross Margin rose 2517.0% year-over-year to 46.84%; the TTM figure through Mar 2025 stood at 35.94% (up 1260.0% YoY), while the FY2023 annual figure was 25.99%, changed N/A from the prior year.
- Gross Margin for Q1 2025 stood at 46.84%, up from 36.73% in the prior quarter.
- The five-year high for Gross Margin was 68.42% in Q4 2022, with the low at 7.23% in Q1 2023.
- The 4-year median for Gross Margin is 29.18% (2023), against an average of 31.9%.
- The sharpest annual moves came in 2023 and 2025: Gross Margin slumped 4234 bps in 2023, then soared 2517 bps in 2025.
- Intelligent Bio Solutions' Gross Margin stood at 68.42% in 2022, then plunged by 62 bps to 26.08% in 2023, then soared by 41 bps to 36.73% in 2024, then increased by 28 bps to 46.84% in 2025.
- Business Quant data shows INBS's Gross Margin at 46.84% in Q1 2025, 36.73% in Q4 2024, and 39.76% in Q3 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 46.84% |
| Dec 31, 2024 | 36.73% |
| Sep 30, 2024 | 39.76% |
| Mar 31, 2024 | 21.67% |
| Dec 31, 2023 | 26.08% |
| Sep 30, 2023 | 29.18% |
| Jun 30, 2023 | 11.19% |
| Mar 31, 2023 | 7.23% |
| Dec 31, 2022 | 68.42% |